Vivos Therapeutics (NASDAQ:VVOS) vs. Medacta Group (OTCMKTS:MEDGF) Head to Head Analysis

Vivos Therapeutics (NASDAQ:VVOS) and Medacta Group (OTCMKTS:MEDGF) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Valuation and Earnings

This table compares Vivos Therapeutics and Medacta Group’s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivos Therapeutics	$16.02 million	0.49	-$23.84 million	($0.71)	-0.37
Medacta Group	N/A	N/A	N/A	N/A	N/A

Medacta Group has lower revenue, but higher earnings than Vivos Therapeutics.

Profitability

This table compares Vivos Therapeutics and Medacta Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vivos Therapeutics	-121.40%	-354.65%	-133.79%
Medacta Group	N/A	N/A	N/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for Vivos Therapeutics and Medacta Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivos Therapeutics	0	0	2	0	3.00
Medacta Group	0	1	1	0	2.50

Institutional and Insider Ownership

15.7% of Vivos Therapeutics shares are held by institutional investors. 9.6% of Vivos Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Vivos Therapeutics beats Medacta Group on 5 of the 8 factors compared between the two stocks.

About Vivos Therapeutics

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.

About Medacta Group

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.